Recalcitrant nasal polyposis: achievement of total remission following treatment with omalizumab

MeSH terms

• Adrenal Cortex Hormones / administration & dosage
• Allergens / immunology
• Animals
• Antibodies, Anti-Idiotypic
• Antibodies, Monoclonal / administration & dosage*
• Antibodies, Monoclonal, Humanized
• Asthma / complications
• Asthma / immunology
• Asthma / physiopathology
• Asthma / therapy*
• Chronic Disease
• Headache
• Humans
• Immunoglobulin E / immunology
• Male
• Middle Aged
• Nasal Obstruction
• Nasal Polyps / complications
• Nasal Polyps / immunology
• Nasal Polyps / physiopathology
• Nasal Polyps / therapy*
• Olfaction Disorders
• Omalizumab
• Pollen / immunology
• Pyroglyphidae / immunology
• Remission Induction
• Rhinitis / complications
• Rhinitis / immunology
• Rhinitis / physiopathology
• Rhinitis / therapy*
• Secondary Prevention
• Sinusitis / complications
• Sinusitis / immunology
• Sinusitis / physiopathology
• Sinusitis / therapy*